GLSI

• 2026-06-04 share offering or dilution eventfreshOpen filing ↗
  “…OF STOCKHOLDERS’ EQUITY FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025 (UNAUDITED) Additional Total Common Stock Paid-in…”
  +1 more passage from the same document

  • “…stock via ATM program, net of costs 39,918 40 492,383 — 492,423 Net loss — — — ( 2,744,780 ) ( 2,744,780 ) Balances, March 31, 2025…”
• 2026-06-01 share offering or dilution eventrecentOpen filing ↗
  “…expenses for the Phase III clinical trial. Investing Activities We did not use or generate cash from investing activities during…”
  +1 more passage from the same document

  • “…provided by financing activities was $11,999,484 during the year ended December 31, 2025, attributable to the sale of common stock…”
• 2026-06-01 listing compliance noticerecentOpen filing ↗
  “…and costly, particularly after we are no longer an “emerging growth company.” Our management and other personnel will…”
• 2026-06-01 capital return (buybacks/dividends)recentOpen filing ↗
  “…during the vesting period due to rounding up of fractional shares, had vested at approximately $ 2,009,657 value and 15,181 shares…”
  +1 more passage from the same document

  • “…and unrecognized at approximately $ 34,157 value. In 2025 and 2024, no shares of common stock grant vested. On January 23,…”
• 2026-06-01 Department of Justice inquiryrecentOpen filing ↗
  “…to permit the import or export of products, or require us to initiate a product recall. The occurrence of any event or penalty…”
  +1 more passage from the same document

  • “…expedite the development or approval process. Other Healthcare Laws and Compliance Requirements Our sales, promotion, medical…”
• 2026-06-01 reverse splitrecentOpen filing ↗
  “…of $ 2,065,366 and net proceeds of $ 1,869,111 , after deducting underwriting discounts and commissions and offering expenses borne…”
  +1 more passage from the same document

  • “…proceeds of $ 2,065,366 and net proceeds of $ 1,869,111 , after deducting underwriting discounts and commissions and offering…”
• 2025-11-14 share offering or dilution eventrecentOpen filing ↗
  “…Sale of common stock via ATM program, net of costs 280,292 280 2,607,965 — 2,608,245 Net loss ( 4,025,278 ) ( 4,025,278 )…”
  +1 more passage from the same document

  • “…used in operating activities: Amortization 1,779 2,709 Stock-based compensation 4,632,642 1,783,566 Changes in operating assets and…”

Recorded SEC filings in plain language — not advice or a prediction.